JNJ-54082730 (Compound 1) is the orally active inhibitor for phosphodiesterase ( PDE ) that inhibits PDE2A , PDE3B , and PDE10A2 with IC 50 s of 0.95 nM, 6.17 μM (pIC 50 =5.21) and 87.1 nM (pIC 50 =7.06), respectively. JNJ-54082730 modulates the activity of AMPA receptor , enhance the synaptic plasticity and promotes the learning and memory function in rats models. JNJ-54082730 can cross blood-brain barrier.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Phosphodiesterase (PDE) | Products > Signaling Pathways > iGluR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.